Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Genomic evolution and chemoresistance in germ-cell tumours

Open access
Taylor-Weiner, Amaro, Zack, Travis, O’Donnell, Elizabeth, Guerriero, Jennifer L., Bernard, Brandon, Reddy, Anita, Han, G. Celine, AlDubayan, Saud, Amin-Mansour, Ali, Schumacher, Steven E., Litchfield, Kevin, Turnbull, Clare, Gabriel, Stacey, Beroukhim, Rameen, Getz, Gad, Carter, Scott L., Hirsch, Michelle S., Letai, Anthony, Sweeney, Christopher, Van Allen, Eliezer M·2016·Nature

Abstract

Germ-cell tumours (GCTs) are derived from germ cells and occur most frequently in the testes. GCTs are histologically heterogeneous and distinctly curable with chemotherapy. Gains of chromosome arm 12p and aneuploidy are nearly universal in GCTs, but specific somatic genomic features driving tumour initiation, chemosensitivity and progression are incompletely characterized. Here, using clinical whole-exome and transcriptome sequencing of precursor, primary (testicular and mediastinal) and chemoresistant metastatic human GCTs, we show that the primary somatic feature of GCTs is highly recurrent chromosome arm level amplifications and reciprocal deletions (reciprocal loss of heterozygosity), variations that are significantly enriched in GCTs compared to 19 other cancer types. These tumours also acquire KRAS mutations during the development from precursor to primary disease, and primary testicular GCTs (TGCTs) are uniformly wild type for TP53. In addition, by functional measurement of apoptotic signalling (BH3 profiling) of fresh tumour and adjacent tissue, we find that primary TGCTs have high mitochondrial priming that facilitates chemotherapy-induced apoptosis. Finally, by phylogenetic analysis of serial TGCTs that emerge with chemotherapy resistance, we show how TGCTs gain additional reciprocal loss of heterozygosity and that this is associated with loss of pluripotency markers (NANOG and POU5F1) in chemoresistant teratomas or transformed carcinomas. Our results demonstrate the distinct genomic features underlying the origins of this disease and associated with the chemosensitivity phenotype, as well as the rare progression to chemoresistance. These results identify the convergence of cancer genomics, mitochondrial priming and GCT evolution, and may provide insights into chemosensitivity and resistance in other cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature20596

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 170

Metadata

Authors
Taylor-Weiner, A., Zack, T., O’Donnell, E., Guerriero, J. L., Bernard, B., Reddy, A., Han, G. C., AlDubayan, S., Amin-Mansour, A., Schumacher, S. E., Litchfield, K., Turnbull, C., Gabriel, S., Beroukhim, R., Getz, G., Carter, S. L., Hirsch, M. S., Letai, A., Sweeney, C., & Van Allen, E. M.
Venue
Nature
Published
2016-11-30
Volume
540
Issue
7631
Pages
114-118
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2557360435
Cited by
170
References
5
FWCI
20.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic evolution and chemoresistance in germ-cell tumours. https://app.cochat.ai/papers/10.1038/nature20596
The paper
Taylor-Weiner, A., Zack, T., O’Donnell, E., Guerriero, J. L., Bernard, B., Reddy, A., Han, G. C., AlDubayan, S., Amin-Mansour, A., Schumacher, S. E., Litchfield, K., Turnbull, C., Gabriel, S., Beroukhim, R., Getz, G., Carter, S. L., Hirsch, M. S., Letai, A., Sweeney, C., & Van Allen, E. M. (2016). Genomic evolution and chemoresistance in germ-cell tumours. Nature. https://doi.org/10.1038/nature20596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.